<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Contraception Assessment Clinical Reference</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
    <style>
        :root {
            --primary: #4361ee;
            --secondary: #3a0ca3;
            --accent: #4cc9f0;
            --light: #f8f9fa;
            --dark: #212529;
            --success: #2d6a4f;
            --warning: #e76f51;
            --danger: #d62828;
            --info: #4895ef;
        }
        
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
            font-family: 'Segoe UI', Tahoma, Geneva, Verdana, sans-serif;
        }
        
        body {
            background-color: var(--light);
            color: var(--dark);
            line-height: 1.6;
        }
        
        .container {
            max-width: 1200px;
            margin: 0 auto;
            padding: 0 20px;
        }
        
        /* Header Styles */
        header {
            background: linear-gradient(135deg, var(--primary), var(--secondary));
            color: white;
            padding: 2rem 0;
            text-align: center;
            box-shadow: 0 4px 12px rgba(0, 0, 0, 0.1);
        }
        
        header h1 {
            font-size: 2.5rem;
            margin-bottom: 0.5rem;
        }
        
        header p {
            font-size: 1.2rem;
            max-width: 700px;
            margin: 0 auto;
        }
        
        /* Navigation */
        nav {
            background-color: white;
            padding: 1rem 0;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.08);
            position: sticky;
            top: 0;
            z-index: 100;
        }
        
        nav ul {
            display: flex;
            flex-wrap: wrap;
            justify-content: center;
            list-style: none;
        }
        
        nav li {
            margin: 0 1rem;
        }
        
        nav a {
            color: var(--dark);
            text-decoration: none;
            font-weight: 600;
            padding: 0.5rem 0.75rem;
            border-radius: 4px;
            transition: all 0.3s ease;
        }
        
        nav a:hover {
            background-color: var(--accent);
            color: white;
        }
        
        /* Section Styles */
        section {
            padding: 3rem 0;
        }
        
        .section-title {
            font-size: 2rem;
            color: var(--primary);
            margin-bottom: 1.5rem;
            text-align: center;
            position: relative;
            padding-bottom: 1rem;
        }
        
        .section-title::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 50%;
            transform: translateX(-50%);
            width: 80px;
            height: 4px;
            background-color: var(--accent);
            border-radius: 2px;
        }
        
        /* Card Styles */
        .card {
            background-color: white;
            border-radius: 8px;
            box-shadow: 0 4px 12px rgba(0, 0, 0, 0.08);
            padding: 1.5rem;
            margin-bottom: 2rem;
            transition: transform 0.3s ease, box-shadow 0.3s ease;
        }
        
        .card:hover {
            transform: translateY(-5px);
            box-shadow: 0 8px 16px rgba(0, 0, 0, 0.12);
        }
        
        .card-header {
            display: flex;
            align-items: center;
            margin-bottom: 1rem;
            border-bottom: 2px solid var(--light);
            padding-bottom: 0.75rem;
        }
        
        .card-icon {
            font-size: 1.5rem;
            margin-right: 1rem;
            color: var(--primary);
        }
        
        .card-title {
            font-size: 1.5rem;
            color: var(--secondary);
        }
        
        /* Table Styles */
        .responsive-table {
            overflow-x: auto;
        }
        
        table {
            width: 100%;
            border-collapse: collapse;
            margin: 1.5rem 0;
        }
        
        th, td {
            padding: 0.75rem;
            text-align: left;
            border-bottom: 1px solid #e0e0e0;
        }
        
        th {
            background-color: var(--primary);
            color: white;
            font-weight: 600;
        }
        
        tr:nth-child(even) {
            background-color: #f8f9fa;
        }
        
        tr:hover {
            background-color: #e9f2ff;
        }
        
        /* List Styles */
        ul.feature-list {
            list-style-type: none;
            padding-left: 0;
        }
        
        ul.feature-list li {
            position: relative;
            padding-left: 2rem;
            margin-bottom: 0.75rem;
        }
        
        ul.feature-list li::before {
            content: '\f00c';
            font-family: 'Font Awesome 6 Free';
            font-weight: 900;
            position: absolute;
            left: 0;
            color: var(--success);
        }
        
        /* Special Populations */
        .population-grid {
            display: grid;
            grid-template-columns: repeat(auto-fill, minmax(300px, 1fr));
            gap: 1.5rem;
        }
        
        .population-card {
            background-color: white;
            border-radius: 8px;
            box-shadow: 0 4px 12px rgba(0, 0, 0, 0.08);
            padding: 1.5rem;
            height: 100%;
        }
        
        .population-title {
            font-size: 1.25rem;
            color: var(--secondary);
            margin-bottom: 1rem;
            display: flex;
            align-items: center;
        }
        
        .population-title i {
            margin-right: 0.5rem;
            color: var(--primary);
        }
        
        /* Footer */
        footer {
            background-color: var(--dark);
            color: white;
            text-align: center;
            padding: 2rem 0;
            margin-top: 3rem;
        }
        
        /* Responsive */
        @media (max-width: 768px) {
            header h1 {
                font-size: 2rem;
            }
            
            .section-title {
                font-size: 1.75rem;
            }
            
            nav ul {
                flex-direction: column;
                align-items: center;
            }
            
            nav li {
                margin: 0.25rem 0;
            }
            
            .population-grid {
                grid-template-columns: 1fr;
            }
        }
    </style>
</head>
<body>
    <header>
        <div class="container">
            <h1><i class="fas fa-stethoscope"></i> Contraception Assessment Clinical Reference</h1>
            <p>A comprehensive guide for healthcare professionals to assess women for contraception methods</p>
        </div>
    </header>
    
    <nav>
        <div class="container">
            <ul>
                <li><a href="#initial-assessment">Initial Assessment</a></li>
                <li><a href="#method-selection">Method Selection</a></li>
                <li><a href="#special-populations">Special Populations</a></li>
                <li><a href="#sti-risk">STI Risk</a></li>
                <li><a href="#quick-start">Quick Start</a></li>
            </ul>
        </div>
    </nav>
    
    <main class="container">
        <section id="initial-assessment">
            <h2 class="section-title">Initial Assessment</h2>
            
            <div class="card">
                <div class="card-header">
                    <i class="fas fa-check-circle card-icon"></i>
                    <h3 class="card-title">Excluding Pregnancy</h3>
                </div>
                <p>Reasonably certain if ANY ONE criterion is met:</p>
                <ul class="feature-list">
                    <li>No intercourse since last normal period/childbirth/abortion</li>
                    <li>Consistent & correct use of reliable contraception</li>
                    <li>Within first 5 days of normal menstrual period</li>
                    <li><21 days postpartum (non-breastfeeding)</li>
                    <li>Fully breastfeeding, amenorrhoeic, <6 months postpartum</li>
                    <li>Within first 5 days after abortion/miscarriage</li>
                    <li>No intercourse >21 days + negative high-sensitivity pregnancy test</li>
                </ul>
            </div>
            
            <div class="card">
                <div class="card-header">
                    <i class="fas fa-clipboard-list card-icon"></i>
                    <h3 class="card-title">History & Discussion</h3>
                </div>
                <ul class="feature-list">
                    <li>Preferred contraceptive method</li>
                    <li>Future pregnancy plans</li>
                    <li>Personal beliefs/views about contraception</li>
                    <li>Partner/family attitudes toward contraception</li>
                    <li>Medical history, medications, allergies</li>
                    <li>STI risk factors</li>
                </ul>
            </div>
        </section>
        
        <section id="method-selection">
            <h2 class="section-title">Contraceptive Method Selection</h2>
            
            <div class="card">
                <div class="card-header">
                    <i class="fas fa-table card-icon"></i>
                    <h3 class="card-title">Methods by Effectiveness</h3>
                </div>
                <div class="responsive-table">
                    <table>
                        <thead>
                            <tr>
                                <th>Method</th>
                                <th>Typical Use Failure Rate</th>
                                <th>Key Considerations</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td><strong>LNG-IUD</strong></td>
                                <td>0.2%</td>
                                <td>5-year duration, lighter periods</td>
                            </tr>
                            <tr>
                                <td><strong>Cu-IUD</strong></td>
                                <td>0.8%</td>
                                <td>10-year duration, heavier periods</td>
                            </tr>
                            <tr>
                                <td><strong>Implant</strong></td>
                                <td>0.05%</td>
                                <td>3-year duration, irregular bleeding</td>
                            </tr>
                            <tr>
                                <td><strong>Injectable</strong></td>
                                <td>6%</td>
                                <td>13-week duration, delayed fertility</td>
                            </tr>
                            <tr>
                                <td><strong>COC Pill</strong></td>
                                <td>9%</td>
                                <td>Daily, VTE risk, regular cycles</td>
                            </tr>
                            <tr>
                                <td><strong>POP</strong></td>
                                <td>9%</td>
                                <td>Daily, minimal VTE risk</td>
                            </tr>
                            <tr>
                                <td><strong>Male Condom</strong></td>
                                <td>18%</td>
                                <td>STI protection</td>
                            </tr>
                            <tr>
                                <td><strong>Fertility Awareness</strong></td>
                                <td>24%</td>
                                <td>Requires training</td>
                            </tr>
                        </tbody>
                    </table>
                </div>
                <p><em>For detailed contraindications, refer to UK Medical Eligibility Criteria (UKMEC)</em></p>
            </div>
        </section>
        
        <section id="special-populations">
            <h2 class="section-title">Special Populations</h2>
            
            <div class="population-grid">
                <div class="population-card">
                    <h3 class="population-title"><i class="fas fa-child"></i> Under 16 Years</h3>
                    <p>Assess Fraser criteria:</p>
                    <ul class="feature-list">
                        <li>Understands advice</li>
                        <li>Cannot be persuaded to inform parents</li>
                        <li>Likely to continue intercourse</li>
                        <li>Physical/mental health likely to suffer without contraception</li>
                        <li>Best interests require treatment without parental consent</li>
                    </ul>
                </div>
                
                <div class="population-card">
                    <h3 class="population-title"><i class="fas fa-heartbeat"></i> Comorbidities</h3>
                    <ul class="feature-list">
                        <li><strong>Menorrhagia:</strong> LNG-IUD (1st line), COC (2nd line)</li>
                        <li><strong>Abnormal bleeding:</strong> Investigate first; avoid implant/injectable</li>
                        <li><strong>Ectopic pregnancy:</strong> All methods acceptable</li>
                        <li><strong>Uterine fibroids:</strong> Hormonal methods OK; IUD only if no cavity distortion</li>
                        <li><strong>Migraine with aura:</strong> Avoid CHC; progestogen-only/IUD acceptable</li>
                        <li><strong>Hypertension:</strong> Avoid CHC if BP â‰¥145/90 or controlled with meds</li>
                        <li><strong>VTE history:</strong> Avoid CHC; progestogen-only/IUD acceptable</li>
                    </ul>
                </div>
                
                <div class="population-card">
                    <h3 class="population-title"><i class="fas fa-baby"></i> Postpartum</h3>
                    <ul class="feature-list">
                        <li><strong>Breastfeeding:</strong> Progestogen-only methods, IUD, implant</li>
                        <li><strong>Non-breastfeeding:</strong> All methods acceptable after 21 days</li>
                    </ul>
                </div>
                
                <div class="population-card">
                    <h3 class="population-title"><i class="fas fa-pills"></i> Drug Interactions</h3>
                    <p><strong>Liver enzyme-inducers:</strong></p>
                    <ul class="feature-list">
                        <li>Avoid COC</li>
                        <li>Increased dose POP or implant/IUD preferred</li>
                    </ul>
                </div>
                
                <div class="population-card">
                    <h3 class="population-title"><i class="fas fa-venus"></i> Menopause</h3>
                    <p>Continue contraception until:</p>
                    <ul class="feature-list">
                        <li>1 year after last period if >50</li>
                        <li>2 years after last period if <50</li>
                    </ul>
                </div>
            </div>
        </section>
        
        <section id="sti-risk">
            <h2 class="section-title">STI Risk Assessment</h2>
            
            <div class="card">
                <div class="card-header">
                    <i class="fas fa-exclamation-triangle card-icon"></i>
                    <h3 class="card-title">Consider Testing If:</h3>
                </div>
                <ul class="feature-list">
                    <li>Under 25 years</li>
                    <li>New or multiple sexual partners</li>
                    <li>History of STIs</li>
                    <li>Inconsistent condom use</li>
                    <li>Men who have sex with men</li>
                    <li>Sex workers</li>
                    <li>From areas with high HIV prevalence</li>
                </ul>
            </div>
        </section>
        
        <section id="quick-start">
            <h2 class="section-title">Quick Starting Contraception</h2>
            
            <div class="card">
                <div class="card-header">
                    <i class="fas fa-rocket card-icon"></i>
                    <h3 class="card-title">Guidelines</h3>
                </div>
                <p>If pregnancy excluded but immediate contraception needed:</p>
                <ul class="feature-list">
                    <li><strong>Can quick start:</strong> CHC (except co-cyprindiol), POP, implant</li>
                    <li><strong>Less preferred:</strong> Injectable (cannot be removed if pregnant)</li>
                </ul>
                <p><em>Quick starting is outside the product license for many contraceptive methods but supported by FSRH guidelines.</em></p>
            </div>
        </section>
    </main>
    
    <footer>
        <div class="container">
            <p>&copy; 2023 Contraception Assessment Clinical Reference | Based on NICE CKS Guidelines</p>
        </div>
    </footer>
</body>
</html>